Company Badge
USPTO Data Jan 1 1976 - Dec 30 2025
9 Patents
#303 in London
#1,861 in United Kingdom
Atopix Therapeutics Limited
Forward Citations = 28
16 inventors:
Atopix Therapeutics Limited
CIPO Patents = 3
EPO Patents = 5
Forward Citations = 28
Loading Chart...
Loading Chart...
16 inventors (with patents filed for the assignee):
Mark Whittaker (3 out of 17 patents)
Graham Michael Wynne (3 out of 14 patents)
Richard Edward Armer (3 out of 11 patents)
4. Eric Roy Pettipher (3 out of 10 patents)
5. Julia Vile (3 out of 8 patents)
6. Frank Schroer (3 out of 5 patents)
7. Aimesther Betancourt (2 out of 4 patents)
8. Katja Grosse-Sender (2 out of 2 patents)
9. Rolf Hilfiker (2 out of 2 patents)
10. Jacques Tonnel (2 out of 2 patents)
11. Marc Lemieux (2 out of 2 patents)
12. Roch Thibert (2 out of 2 patents)
13. Sylvie Blanchet (1 out of 4 patents)
14. Guillaume Léonard Pierre Dewaele (1 out of 1 patent)
15. Tony Pintus (1 out of 1 patent)
9 patents:
3. 9828359 - Process for the preparation of 3-substituted (indol-1-yl)-acetic acid esters (2017-11-28),
6. 8980918 - Amorphous (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid (2015-03-17),
Atopix Therapeutics Limited is a biopharmaceutical company focusing on developing novel drugs for the treatment of allergic diseases. The company's innovative approach targets the underlying cause of allergic inflammation to provide long-lasting relief for patients. With a team of experienced researchers and clinicians, Atopix is dedicated to advancing therapeutics that improve the lives of those suffering from allergies.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
3 patents (CIPO):
Please report any incorrect information to support@idiyas.com
5 patents (EPO):
Please report any incorrect information to support@idiyas.com